Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol with or without exercise rehabilitation after CABG
IRCT20120215009014N221Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of resveratrol in coronary arteriosclerosis (3 arms), sponsored by Islamic Azad University. Primary endpoints: Change in inflammatory markers and Change in lipid profile. Started Oct 2016; status: completed.
02
Drugs
resveratrol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20120215009014N221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N221.